Do the current performance-based schemes in Italy really work? "Success fee": a novel measure for cost-containment of drug expenditure.

Do the current performance-based schemes in Italy really work? "Success fee": a novel measure for cost-containment of drug expenditure.

Item
http://www.wikidata.org/entity/Q34667549
Feasibility and attractiveness of indication value-based pricing in key EU countriesManaged Entry Agreements for Oncology Drugs: Lessons from the European Experience to Inform the FutureThe Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications.Sustainable Financing of Innovative Therapies: A Review of Approaches.Financial consequences of a payment-by-results scheme in Catalonia: gefitinib in advanced EGFR-mutation positive non-small-cell lung cancer.Linking the Price of Cancer Drug Treatments to Their Clinical Value.Unlocking the potential of established products: toward new incentives rewarding innovation in Europe.Gene therapies: the challenge of super-high-cost treatments and how to pay for them.CASE STUDY ON AN IPILIMUMAB COST-CONTAINMENT STRATEGY IN AN ITALIAN HOSPITAL.The Use of Surrogate and Patient-Relevant Endpoints in Outcomes-Based Market Access Agreements : Current Debate.Risk-Sharing Agreements in the EU: A Systematic Review of Major Trends.Approaches to manage 'affordability' of high budget impact medicines in key EU countries.Managed Entry Agreements for Pharmaceuticals in the Context of Adaptive Pathways in Europe.
P2860

Do the current performance-based schemes in Italy really work? "Success fee": a novel measure for cost-containment of drug expenditure.

Item
http://www.wikidata.org/entity/Q34667549
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Do the current performance-bas ...... ntainment of drug expenditure.
@ast
Do the current performance-bas ...... ntainment of drug expenditure.
@en
Do the current performance-bas ...... ntainment of drug expenditure.
@nl
type
label
Do the current performance-bas ...... ntainment of drug expenditure.
@ast
Do the current performance-bas ...... ntainment of drug expenditure.
@en
Do the current performance-bas ...... ntainment of drug expenditure.
@nl
prefLabel
Do the current performance-bas ...... ntainment of drug expenditure.
@ast
Do the current performance-bas ...... ntainment of drug expenditure.
@en
Do the current performance-bas ...... ntainment of drug expenditure.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Do the current performance-bas ...... ntainment of drug expenditure.
@en
P2093
P304
P31
P356
10.1016/J.JVAL.2014.09.007
P433
P478
P50
P577
P5875
P698
P921